3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
HIV Infections
1
Cervical Cancer Screening
1
Breast Neoplasms
1
Interventions
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Fluorouracil
2
Etoposide
2
Cyclophosphamide
2
liposomal doxorubicin
1
fludarabine
1
dehydroftorafur
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
axicabtagene ciloleucel
1
Zidovudine
1
X-Rays
1
Vincristine
1
Valganciclovir
1
Triage
1
Therapeutics
1
Standard of Care
1
Sodium Chloride
1
Smoking Devices
1
Sirolimus
1
Sigmoidoscopy
1
Sentinel Lymph Node Biopsy
1
Rituximab
1
Restraint, Physical
1
Raltegravir Potassium
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Coal Tar
×
1 year
×
Clear all
NCT07225530
2026-02-25
(iSTAR)
Columbia University
Phase NA
Recruiting
600 enrolled